Loading…
Reported covered position: Health Policy Advisor and Counsel, Senate Finance Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Source: Senate LDA
| NATIONAL ALLIANCE FOR CARE AT HOME |
| 8 |
| 2025–2026 |
| ALLIANCE OF COMMUNITY HEALTH PLANS | 7 | 2021–2022 |
| BRIGHTSPRING HEALTH SERVICES | 7 | 2025–2026 |
| PFIZER | 7 | 2021–2022 |
| LINCOLN POLICY GROUP ON BEHALF OF VISITING NURSE ASSOCIATION HEALTH GROUP | 3 | 2021 |
| NORTH AMERICAN PARTNERS IN ANESTHESIA | 3 | 2022–2023 |
| VEKTOR MEDICAL | 3 | 2025 |
| FIND SOLACE, INC. | 2 | 2023 |
| HUMACYTE | 2 | 2023 |
| PRUITTHEALTH CORPORATION | 1 | 2022 |
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC HEALTH PLAN · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC HEALTH PLAN · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC HEALTH PLAN · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC HEALTH PLAN · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: UPMC · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services specifically; H.R. 5142, Home Health Stabilization Act of 2025.
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Home Health Stabilization Act of 2025
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services specifically; H.R. 5142, Home Health Stabilization Act of 2025
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Kidney Care Access Protection Act
Client: KIDNEY CARE PARTNERS · Firm: FEDERAL HEALTH POLICY STRATEGIES
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: BRIGHTSPRING HEALTH SERVICES · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2026 · third_quarter · Q3
issues related to technology and clinically appropriate use of AI; issues related to Medicare Advantage program function.
issues related to technology and clinically appropriate use of AI; issues related to Medicare Advantage program function.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2026 · second_quarter · Q2
Issues related to Medicaid community engagement interim final rule; issues related to technology and clinically appropriate use of AI; issues related to Medicare Advantage program function.
Issues related to Medicaid community engagement interim final rule; issues related to technology and clinically appropriate use of AI; issues related to Medicare Advantage program function.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2026 · first_quarter · Q1
Issues related to CMS proposed regulations on Medicare Advantage policy and rate proposals for CY 2027; issues related to risk adjustment status of institutional versus community-based beneficiaries in Medicare Advantage; issues related to technology and clinically appropriate use of AI.
Issues related to CMS proposed regulations on Medicare Advantage policy and rate proposals for CY 2027; issues related to risk adjustment status of institutional versus community-based beneficiaries in Medicare Advantage; issues related to technology and clinically appropriate use of AI.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services specifically; H.R. 5142, Home Health Stabilization Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · fourth_quarter · Q4
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; issues related to CMS program treatment of institutionalized and community-dwelling enrollees.
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; issues related to CMS program treatment of institutionalized and community-dwelling enrolled.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VEKTOR MEDICAL via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Medicare coverage and reimbursement of software as a service
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services specifically; H.R. 5142, Home Health Stabilization Act of 2025
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · third_quarter · Q3
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VEKTOR MEDICAL via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Medicare coverage and reimbursement of software as a service.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services specifically
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · Q2
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance; H.R. 1, One Big Beautiful Bill Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
VEKTOR MEDICAL via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · RR
Medicare reimbursement issues
BRIGHTSPRING HEALTH SERVICES via FEDERAL HEALTH POLICY STRATEGIES
2025 · second_quarter · RR
Issues related to long term care pharmacy and adjacent community-based services for seniors and disabled populations; Medicare home health agency prospective payment system
Issues related to long term care pharmacy and adjacent community-based services for seniors and disabled populations; Medicare home health agency prospective payment system
Issues related to long term care pharmacy and adjacent community-based services for seniors and disabled populations; Medicare home health agency prospective payment system
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance
Issues related to the Medicare Advantage program; issues related to Medicaid program financing and ongoing coverage of Marketplace insurance
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Issues related to Medicaid program financing; issues related to continuous coveage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; isssues related to HRSA 340B program; government funding and continuing resolutions.
Issues related to Medicaid program financing; issues related to continuous coveage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; isssues related to HRSA 340B program; government funding and continuing resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
Issues related to Medicare home health agency (HHA) benefit structure and payment system; issues related to Medicare hospice benefit and payment system; issues related to Medicaid policy generally and home and community-based services specifically
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · Q1
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to End-Stage Renal Disease (ESRD) program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; issues related to promotion of clinical innovation and labor cost increases in the Medicare End-Stage Renal Disease (ESRD) program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via FEDERAL HEALTH POLICY STRATEGIES
2025 · first_quarter · RR
Issues related to Medicare program policy affecting home health and hospice agencies
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · 4T
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Issues related to the Medicare Advantage program and pharmacy access issues; issues related to Medicaid managed care organization rate setting
Issues related to the Medicare Advantage program and pharmacy access issues; issues related to Medicaid managed care organization rate setting
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025, Government Funding legislation, continuing resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2024 · fourth_quarter · Q4
H.R. 5067/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074/S.4510, Kidney Patient Act; issues related to CY 2025 End-Stage Renal Disease (ESRD) Proposed Payment Systems (PPS) final rule
H.R. 5067/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074/S.4510, Kidney Patient Act; issues related to CY 2025 End-Stage Renal Disease (ESRD) Proposed Payment Systems (PPS) final rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Issues related to the Medicare Advantage program and pharmacy access issues; issues related to Medicaid managed care organization rate setting
Issues related to the Medicare Advantage program and pharmacy access issues; issues related to Medicaid managed care organization rate setting
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Issues associated with payment accuracy in Medicare Home Health Agencies (HHA) payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2024 · third_quarter · Q3
H.R. 5067/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074/S.4510, Kidney Patient Act; issues related to CY 2025 End-Stage Renal Disease (ESRD) Proposed Payment Systems (PPS) proposed rule
H.R. 5067/S. 4469, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; H.R. 5074/S.4510, Kidney Patient Act; issues related to CY 2025 End-Stage Renal Disease (ESRD) Proposed Payment Systems (PPS) proposed rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Issues related to the Medicare Advantage program and pharmacy access issues
Issues related to the Medicare Advantage program and pharmacy access issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Issues related to FY 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to Fy 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act; Issues related to CMS proposed rule for hospice for FY 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2024 · second_quarter · Q2
H.R. 5067/S. 4911, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074/S.4510, Kidney Patient Act.
H.R. 5067/S. 4911, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074/S.4510, Kidney Patient Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Issues related to the Medicare Advantage program and pharmacy access issues
Issues related to the Medicare Advantage program and pharmacy access issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2024 · first_quarter · Q1
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 5067, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074, Kidney Patient Act.
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 5067, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074, Kidney Patient Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · 4T
Issues related to S. 1976/H.R. 4014 Preserving Patient Access to Home Infusion Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues related to the Medicare Advantage program and pharmacy access issues
Issues related to the Medicare Advantage program and pharmacy access issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues related to S. 1976/H.R. 4014 Preserving Patient Access to Home Infusion Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 5067, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074, Kidney Patient Act
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 5067, Chronic Kidney Disease Improvement in Research and Training Act; H.R. 6860, Restore Protections for Dialysis Patients Act; H.R. 5074, Kidney Patient Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FIND SOLACE, INC. via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · Q4
Funding opportunities related to increasing health equity, improving access
Filing targets: Health & Human Services, Dept of (HHS)
FIND SOLACE, INC. via FEDERAL HEALTH POLICY STRATEGIES
2023 · fourth_quarter · RR
Issues affecting health equity and care quality in Medicare and Medicaid
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Issues related to the Medicare Advantage program and pharmacy access issues; Requirements Related to the Mental Health Parity and Addiction Equity Act, Doc. No. 2023-15945
Issues related to the Medicare Advantage program and pharmacy access issues; Requirements Related to the Mental Health Parity and Addiction Equity Act, Doc. No. 2023-15945
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Issues related to CMS proposed rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedy rules; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Issues related to CMS proposed rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedy rules; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Issues related to S. 1976/H.R. 4014 Preserving Patient Access to Home Infusion Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Issues associated with payment accuracy in Medicare HHA payments; S. 2137/H.R. 5159, Preserving Access to Home Health Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2023 · third_quarter · Q3
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 5067, Chronic Kidney Disease Improvement in Research and Training Act
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule; H.R. 5067, Chronic Kidney Disease Improvement in Research and Training Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2023 · second_quarter · Q2
Issues related to the Medicare Advantage program and pharmacy access issues
Issues related to the Medicare Advantage program and pharmacy access issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2023 · second_quarter · Q2
Issues related to inpatient prospective payment system (IPPS) proposed rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to hospital-based outpatient department (HOPD) 340B remedy proposed rule; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials.
Issues related to inpatient prospective payment system (IPPS) proposed rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to hospital-based outpatient department (HOPD) 340B remedy proposed rule; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2023 · second_quarter · Q2
Issues related to S. 1976/H.R. 4014 Preserving Patient Access to Home Infusion Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2023 · second_quarter · Q2
Issues related to FY 2024 proposed hospice wage index rule; issues associated with payment accuracy in Medicare HHA payments.
Issues related to FY 2024 proposed hospice wage index rule; issues associated with payment accuracy in Medicare HHA payments.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2023 · second_quarter · Q2
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule
Policies affecting the provision of renal dialysis services; CMS 1782-P, Calendar Year 2024 End-Stage Renal Disease Prospective Payment System Proposed Rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE PARTNERS via FEDERAL HEALTH POLICY STRATEGIES
2023 · second_quarter · RR
Issues related to care for individuals with End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD).
Issues related to care for individuals with End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD).
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
CY 2024 Advance Notice of Methodological Changes and Parts C & D Capitation Rates; CY 2024 proposed rule relating to policy and technical changes to the Medicare Advantage and Medicare prescription drug programs
CY 2024 Advance Notice of Methodological Changes and Parts C & D Capitation Rates; CY 2024 proposed rule relating to policy and technical changes to the Medicare Advantage and Medicare prescription drug programs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
Issues related to CMS inpatient hospital prospective payment system proposed rule development; issues related to House Energy and Commerce Committee hearings on heath care transparency; isssues related to CMS Advance Notice of Methodological Changes and Parts C & D Capitation Rates for 2024; issues related to CMS proposed rule relating to policy and technical changes to Medicare Advantage and Prescription Drug Programs; issues related to pending expiration of COVID-19 Public Health Emergency.
Issues related to CMS inpatient hospital prospective payment system proposed rule development; issues related to House Energy and Commerce Committee hearings on heath care transparency; isssues related to CMS Advance Notice of Methodological Changes and Parts C & D Capitation Rates for 2024; issues related to CMS proposed rule relating to policy and technical changes to Medicare Advantage and Prescription Drug Programs; issues related to pending expiration of COVID-19 Public Health Emergency.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
Issues related to S. 2652/H.R. 5067 Preserving Patient Access to Home Infusion Act, from the 117th Congress
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NORTH AMERICAN PARTNERS IN ANESTHESIA via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
Implementation of the No Surprises Act
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
S. 2562; H.R. 5514, the Choose Home Care Act of 2021; issues related to the CMS Proposed Home Health Prospective Payment System Proposed Rule for 2022
S. 2562; H.R. 5514, the Choose Home Care Act of 2021; issues related to the CMS Proposed Home Health Prospective Payment System Proposed Rule for 2022
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
Policies relating to access to, and reimbursement for, regenerative medicine therapies
Policies relating to access to, and reimbursement for, regenerative medicine therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · Q1
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE via FEDERAL HEALTH POLICY STRATEGIES
2023 · first_quarter · RR
Access to and reimbursement for innovative regenerative medicine therapies
Access to and reimbursement for innovative regenerative medicine therapies
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Programs H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act H.R. 2167, Consolidated Appropriations Act of 2023
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Programs H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act H.R. 2167, Consolidated Appropriations Act of 2023
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act H.R. 2167, Consolidated Appropriations Act of 2023
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act H.R. 4040, Advancing Telehealth Beyond COVID-19 ActH.R. 2167, Consolidated Appropriations Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
Drug pricing reform S. 912/H.R. 197 S.91 the Protecting Seniors Through Immunization Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
S. 2652/H.R. 5067 Preserving Patient Access to Home Infusion Act; H.R. 5376, Inflation Reduction Act; issues related to the CMS CY 2023 Home Health Prospective Payment System Proposed Rule;H.R. 2167, Consolidated Appropriations Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NORTH AMERICAN PARTNERS IN ANESTHESIA via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
S. 2562; H.R. 5514, the Choose Home Care Act of 2021 Issues related to the CMS Proposed Home Health Prospective Payment System Proposed Rule for 2023 H.R. 8581/S. 4605, Preserving Access to Home Health Act H.R. 2167, Consolidated Appropriations Act of 2023
S. 2562; H.R. 5514, the Choose Home Care Act of 2021 Issues related to the CMS Proposed Home Health Prospective Payment System Proposed Rule for 2023 H.R. 8581/S. 4605, Preserving Access to Home Health Act H.R. 2167, Consolidated Appropriations Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
Issues related to CY 2023 CMS End Stage Renal Disease Prospective Payment System Proposed Rule H.R. 8594/S. 4650, Restoring Protections for Dialysis Patients ActH.R. 2167, Consolidated Appropriations Act of 2023
Issues related to CY 2023 CMS End Stage Renal Disease Prospective Payment System Proposed Rule H.R. 8594/S. 4650, Restoring Protections for Dialysis Patients ActH.R. 2167, Consolidated Appropriations Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · Q4
H.R. 4911, Medicare Advantage Quality Payment Relief Act S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021 S. 2411/ H.R. 533 Stop COVID-19 Test Surprise Medical Bills Act of 2021 H.R. 5376 Inflation Reduction Act H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act H.R. 2167, Consolidated Appropriations Act of 2023
H.R. 4911, Medicare Advantage Quality Payment Relief Act S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021 S. 2411/ H.R. 533 Stop COVID-19 Test Surprise Medical Bills Act of 2021 H.R. 5376 Inflation Reduction Act H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act H.R. 2167, Consolidated Appropriations Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NORTH AMERICAN PARTNERS IN ANESTHESIA via FEDERAL HEALTH POLICY STRATEGIES
2022 · fourth_quarter · RR
Surprise billing implementation
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Programs H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Programs H.R. 3173/S. 3018, Improving Seniors Timely Access to Care Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act
H.R. 5376, Inflation Reduction Act; issues related to proposed CMS/HHS rules governing the hospital inpatient and outpatient prospective payment systems and the physician fee schedule; issues related to operation of the CARES Act Provider Relief Fund; S. 1568/H.R. 4407 TRAIN Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
Drug pricing reform, H.R.3-Elijah E. Cummings Lower Drug Costs Now Act Biosimilar utilization policy S. 912/H.R. 197 S.91 the Protecting Seniors Through Immunization Act of 2021 HR 1978--Protecting Seniors Through Immunization Act of 2021 HR 5376 Inflation Reduction Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTION CARE via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
S. 2652/H.R. 5067 Preserving Patient Access to Home Infusion Act; H.R. 5376, Inflation Reduction Act; issues related to the CMS CY 2023 Home Health Prospective Payment System Proposed Rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
S. 2562; H.R. 5514, the Choose Home Care Act of 2021; issues related to the CMS Proposed Home Health Prospective Payment System Proposed Rule for 2023; H.R. 8581/S. 4605, Preserving Access to Home Health Act
S. 2562; H.R. 5514, the Choose Home Care Act of 2021; issues related to the CMS Proposed Home Health Prospective Payment System Proposed Rule for 2023; H.R. 8581/S. 4605, Preserving Access to Home Health Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
Issues related to CY 2022 CMS End Stage Renal Disease Prospective Payment System Proposed Rule H.R. 8594/S. 4650, Restoring Protections for Dialysis Patients Act
Issues related to CY 2022 CMS End Stage Renal Disease Prospective Payment System Proposed Rule H.R. 8594/S. 4650, Restoring Protections for Dialysis Patients Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via FEDERAL HEALTH POLICY STRATEGIES
2022 · third_quarter · Q3
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; S. 2411/ H.R. 533 Stop COVID-19 Test Surprise Medical Bills Act of 2021; H.R. 5376 Build Back Better Act
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; S. 2411/ H.R. 533 Stop COVID-19 Test Surprise Medical Bills Act of 2021; H.R. 5376 Build Back Better Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via FEDERAL HEALTH POLICY STRATEGIES
2022 · second_quarter · Q2
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; CMS 4192-P CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Programs
H.R. 4911, Medicare Advantage Quality Payment Relief Act; S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021; CMS 4192-P CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Programs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5142, Home Health Stabilization Act of 2025; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 1, One Big Beautiful Bill Act H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act H.R. 5142, Home Health Stabilization Act of 2025
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE